MDT

89.82

+1.17%↑

VEEV

281.68

+0.62%↑

A

114.48

-0.44%↓

WBA

11.5

-0.17%↓

HQY

98.08

-0.93%↓

MDT

89.82

+1.17%↑

VEEV

281.68

+0.62%↑

A

114.48

-0.44%↓

WBA

11.5

-0.17%↓

HQY

98.08

-0.93%↓

MDT

89.82

+1.17%↑

VEEV

281.68

+0.62%↑

A

114.48

-0.44%↓

WBA

11.5

-0.17%↓

HQY

98.08

-0.93%↓

MDT

89.82

+1.17%↑

VEEV

281.68

+0.62%↑

A

114.48

-0.44%↓

WBA

11.5

-0.17%↓

HQY

98.08

-0.93%↓

MDT

89.82

+1.17%↑

VEEV

281.68

+0.62%↑

A

114.48

-0.44%↓

WBA

11.5

-0.17%↓

HQY

98.08

-0.93%↓

Search

Cytek Biosciences Inc

Abrir

SetorSaúde

3.17 -4.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.15

Máximo

3.35

Indicadores-chave

By Trading Economics

Rendimento

-21M

-11M

Vendas

-16M

41M

Margem de lucro

-27.503

Funcionários

663

EBITDA

-13M

-15M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+77.47% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-68M

424M

Abertura anterior

7.97

Fecho anterior

3.17

Sentimento de Notícias

By Acuity

50%

50%

169 / 376 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Cytek Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de jul. de 2025, 23:34 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

17 de jul. de 2025, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17 de jul. de 2025, 21:04 UTC

Grandes Movimentos do Mercado
Aquisições, Fusões, Aquisições de Empresas

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

17 de jul. de 2025, 23:43 UTC

Conversa de Mercado

Gold Edges Higher on Possible Position Adjustments -- Market Talk

17 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

17 de jul. de 2025, 22:47 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

17 de jul. de 2025, 22:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

17 de jul. de 2025, 22:46 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

17 de jul. de 2025, 22:43 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

17 de jul. de 2025, 22:43 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

17 de jul. de 2025, 22:40 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 de jul. de 2025, 22:40 UTC

Aquisições, Fusões, Aquisições de Empresas

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 de jul. de 2025, 22:30 UTC

Conversa de Mercado
Ganhos

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

17 de jul. de 2025, 22:20 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

17 de jul. de 2025, 22:20 UTC

Conversa de Mercado
Ganhos

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

17 de jul. de 2025, 22:04 UTC

Conversa de Mercado
Ganhos

Netflix Redesign Done to Match Current Capabilities -- Market Talk

17 de jul. de 2025, 22:03 UTC

Aquisições, Fusões, Aquisições de Empresas

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

17 de jul. de 2025, 21:58 UTC

Conversa de Mercado
Ganhos

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

17 de jul. de 2025, 21:57 UTC

Ganhos

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 de jul. de 2025, 21:47 UTC

Ganhos

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

17 de jul. de 2025, 21:45 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de jul. de 2025, 21:45 UTC

Conversa de Mercado

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17 de jul. de 2025, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

17 de jul. de 2025, 21:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 de jul. de 2025, 21:05 UTC

Ganhos

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 de jul. de 2025, 21:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

17 de jul. de 2025, 21:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 de jul. de 2025, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17 de jul. de 2025, 20:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

17 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

Comparação entre Pares

Variação de preço

Cytek Biosciences Inc Previsão

Preço-alvo

By TipRanks

77.47% parte superior

Previsão para 12 meses

Média 5.75 USD  77.47%

Máximo 8 USD

Mínimo 4 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

4 ratings

2

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

3.7 / 3.8Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

169 / 376 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.